| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8105618 | GALDERMA LABS LP | Dermatological/cosmetic gels comprising at least one retinoid and/or retinoid salt and benzoyl peroxide |
Dec, 2022
(9 months ago) | |
| US8241649 | GALDERMA LABS LP | Dermatological/cosmetic gels comprising at least one retinoid and/or retinoid salt and benzoyl peroxide |
Dec, 2022
(9 months ago) | |
| US8809305 | GALDERMA LABS LP | Administration of adapalene and benzoyl peroxide for the long-term treatment of acne vulgaris |
Dec, 2022
(9 months ago) | |
| US8936800 | GALDERMA LABS LP | Gel composition for treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt |
Dec, 2022
(9 months ago) | |
| US7964202 | GALDERMA LABS LP | Method for treatment of common acne |
Sep, 2024
(11 months from now) | |
| US7820186 | GALDERMA LABS LP | Gel composition for once-daily treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt |
Nov, 2025
(2 years from now) | |
| US8445543 | GALDERMA LABS LP | Combinations of adapalene and benzoyl peroxide for treating acne lesions |
Jul, 2027
(3 years from now) | |
| US8071644 | GALDERMA LABS LP | Combinations of adapalene and benzoyl peroxide for treating acne lesions |
Jul, 2027
(3 years from now) | |
| US8129362 | GALDERMA LABS LP | Combination/association of adapalene and benzoyl peroxide for treating acne lesions |
Jul, 2027
(3 years from now) | |
| US8080537 | GALDERMA LABS LP | Combinations of adapalene and benzoyl peroxide for treating acne lesions |
Jul, 2027
(3 years from now) | |
Epiduo is owned by Galderma Labs Lp.
Epiduo contains Adapalene; Benzoyl Peroxide.
Epiduo has a total of 10 drug patents out of which 4 drug patents have expired.
Expired drug patents of Epiduo are:
- US8105618
- US8241649
- US8809305
- US8936800
Epiduo was authorised for market use on 08 December, 2008.
Epiduo is available in gel;topical dosage forms.
Epiduo can be used as treatment of acne.
The generics of Epiduo are possible to be released after 18 July, 2027.
Drugs and Companies using ADAPALENE; BENZOYL PEROXIDE ingredient
Market Authorisation Date: 08 December, 2008
Treatment: Treatment of acne
Dosage: GEL;TOPICAL
EPIDUO family patents
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic